1
|
Genardi S, Morgun E, Wang CR. CD1-Restricted T Cells in Inflammatory Skin Diseases. J Invest Dermatol 2022; 142:768-773. [PMID: 34130802 PMCID: PMC8665943 DOI: 10.1016/j.jid.2021.03.033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Revised: 03/17/2021] [Accepted: 03/21/2021] [Indexed: 12/14/2022]
Abstract
Autoimmunity results from the breaking of immune tolerance, leading to inflammation and pathology. Although well studied in the conventional T-cell field, the role of nonconventional T cells in autoimmunity is less understood. CD1-restricted T cells recognize lipid antigens rather than peptide antigens and have been implicated in various autoimmune skin conditions, including psoriasis and atopic dermatitis. In this review, we will discuss the self-lipids that CD1-restricted T cells recognize and how these T cells become aberrantly regulated in pathogenic skin conditions.
Collapse
Affiliation(s)
- Samantha Genardi
- Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
| | - Eva Morgun
- Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
| | - Chyung-Ru Wang
- Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
| |
Collapse
|
2
|
Stigmasterol Alleviates Cutaneous Allergic Responses in Rodents. BIOMED RESEARCH INTERNATIONAL 2018; 2018:3984068. [PMID: 30140696 PMCID: PMC6081592 DOI: 10.1155/2018/3984068] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/28/2018] [Revised: 05/14/2018] [Accepted: 06/25/2018] [Indexed: 12/16/2022]
Abstract
The therapeutic potential of stigmasterol, a natural steroid alcohol with established immune-modulatory properties, was assessed on allergic cutaneous responses. We examined its suppressive effect on immunoglobulin E (IgE)-mediated active cutaneous anaphylaxis (ACA), compound 48/80 (C48/80)-induced pruritus, and irritant dermatitis induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Stigmasterol at 10–100 mg/kg significantly inhibited ACA with reduction in reaction area and concentration of the extravasated Evans blue dye. Given at 50 and 100 mg/kg, stigmasterol significantly inhibited C48/80-induced scratching behaviour when compared to saline-treated C48/80-injected control. Skin histopathology of injected sites confirmed that stigmasterol reduced mast cell trafficking and degranulation associated with C48/80-induced pruritus. Stigmasterol controlled inflammatory features such as ear skin oedema and neutrophilia and also reduced serum levels of TNFα induced by topical application of TPA. Epidermal layer thickening and inflammatory cell infiltration of ear skin tissue were significantly reduced by stigmasterol. Taken together, stigmasterol demonstrates significant potential as a molecule of interest in allergic skin disease therapy.
Collapse
|
3
|
Pre-clinical efficacy assessment of Malva sylvestris on chronic skin inflammation. Biomed Pharmacother 2017; 93:852-860. [PMID: 28711022 DOI: 10.1016/j.biopha.2017.06.083] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2017] [Revised: 06/01/2017] [Accepted: 06/20/2017] [Indexed: 11/21/2022] Open
Abstract
In the search for improved quality of life, the treatment of skin diseases like psoriasis (hyperproliferative disease) is valid, since it causes huge social discomfort to the patient. In this context, earlier studies showed that Malva sylvestris L. has anti-inflammatory activity demonstrated by acute animal models of skin inflammation, becoming a promising target for further studies. The present investigation aimed to verify the effect of hydroalcoholic extract of M. sylvestris (HEMS) on the chronic inflammatory and hyperproliferative response caused by multiple applications of 12-O-tetradecanoylphorbol-13-acetate (TPA) on mouse ears. Topical application of HEMS reduced oedema, leukocyte migration (mono- and polymorphonuclear cells) and keratinocyte hyperproliferation, confirmed by histology and proliferating cell nuclear antigen (PCNA) immunostaining. It was found that the anti-inflammatory effects of the extract did not involve the glucocorticoid system, and its incubation with HaCaT keratinocytes caused low toxicity and reduced cell proliferation by apoptosis. Thus, HEMS proved to be effective as an anti-psoriatic therapy, with the ability to prevent keratinocyte hyperproliferation and with low toxicity by topical application.
Collapse
|
4
|
Rodriguez-Sanchez DG, Flores-García M, Silva-Platas C, Rizzo S, Torre-Amione G, De la Peña-Diaz A, Hernández-Brenes C, García-Rivas G. Isolation and chemical identification of lipid derivatives from avocado (Persea americana) pulp with antiplatelet and antithrombotic activities. Food Funct 2015; 6:193-203. [DOI: 10.1039/c4fo00610k] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Bioassay-guided isolation of acetogenins from avocado pulp within vitroantiplatelet aggregation andin vivoantithrombotic effects in CD1 mice.
Collapse
Affiliation(s)
| | - Mirthala Flores-García
- Departamento de Biología Molecular
- Instituto Nacional de Cardiología Ignacio Chavéz
- México City
- Mexico
| | - Christian Silva-Platas
- Cátedra de Cardiología y Medicina Vascular
- Escuela de Medicina
- Tecnológico de Monterrey
- Monterrey
- Mexico
| | - Sheryl Rizzo
- Cátedra de Cardiología y Medicina Vascular
- Escuela de Medicina
- Tecnológico de Monterrey
- Monterrey
- Mexico
| | - Guillermo Torre-Amione
- Cátedra de Cardiología y Medicina Vascular
- Escuela de Medicina
- Tecnológico de Monterrey
- Monterrey
- Mexico
| | - Aurora De la Peña-Diaz
- Departamento de Biología Molecular
- Instituto Nacional de Cardiología Ignacio Chavéz
- México City
- Mexico
- Departamento de Farmacología
| | - Carmen Hernández-Brenes
- Departamento de Biotecnología y Alimentos
- Escuela de Biotecnología e Ingeniería de Alimentos
- Tecnológico de Monterrey
- Monterrey
- Mexico
| | - Gerardo García-Rivas
- Cátedra de Cardiología y Medicina Vascular
- Escuela de Medicina
- Tecnológico de Monterrey
- Monterrey
- Mexico
| |
Collapse
|
5
|
Hall CJ, Wicker SM, Chien AT, Tromp A, Lawrence LM, Sun X, Krissansen GW, Crosier KE, Crosier PS. Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents. Dis Model Mech 2014; 7:1069-81. [PMID: 25038060 PMCID: PMC4142727 DOI: 10.1242/dmm.016873] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Inflammation is an important and appropriate host response to infection or injury. However, dysregulation of this response, with resulting persistent or inappropriate inflammation, underlies a broad range of pathological processes, from inflammatory dermatoses to type 2 diabetes and cancer. As such, identifying new drugs to suppress inflammation is an area of intense interest. Despite notable successes, there still exists an unmet need for new effective therapeutic approaches to treat inflammation. Traditional drug discovery, including structure-based drug design, have largely fallen short of satisfying this unmet need. With faster development times and reduced safety and pharmacokinetic uncertainty, drug repositioning – the process of finding new uses for existing drugs – is emerging as an alternative strategy to traditional drug design that promises an improved risk-reward trade-off. Using a zebrafish in vivo neutrophil migration assay, we undertook a drug repositioning screen to identify unknown anti-inflammatory activities for known drugs. By interrogating a library of 1280 approved drugs for their ability to suppress the recruitment of neutrophils to tail fin injury, we identified a number of drugs with significant anti-inflammatory activity that have not previously been characterized as general anti-inflammatories. Importantly, we reveal that the ten most potent repositioned drugs from our zebrafish screen displayed conserved anti-inflammatory activity in a mouse model of skin inflammation (atopic dermatitis). This study provides compelling evidence that exploiting the zebrafish as an in vivo drug repositioning platform holds promise as a strategy to reveal new anti-inflammatory activities for existing drugs.
Collapse
Affiliation(s)
- Christopher J Hall
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - Sophie M Wicker
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - An-Tzu Chien
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - Alisha Tromp
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - Lisa M Lawrence
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - Xueying Sun
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - Geoffrey W Krissansen
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - Kathryn E Crosier
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| | - Philip S Crosier
- Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand
| |
Collapse
|
6
|
Mruwat R, Cohen Y, Yedgar S. Phospholipase A2 inhibition as potential therapy for inflammatory skin diseases. Immunotherapy 2013; 5:315-7. [DOI: 10.2217/imt.13.18] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Affiliation(s)
- Rufayda Mruwat
- Department of Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem, Israel 91120
| | - Yuval Cohen
- Morria Biopharmaceuticals PLC, 53 Davies Street, London W1K 5JH, UK
| | - Saul Yedgar
- Department of Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem, Israel 91120
| |
Collapse
|
7
|
Dan P, Rosenblat G, Yedgar S. Phospholipase A2 activities in skin physiology and pathology. Eur J Pharmacol 2012; 691:1-8. [DOI: 10.1016/j.ejphar.2012.07.023] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2011] [Revised: 06/21/2012] [Accepted: 07/02/2012] [Indexed: 01/22/2023]
|